26 / 144
26
PERGUNTAS & RESPOSTAS
EMD
- Edema Macular Diabético
edema macular podem condicionar esse mesmo processo.
Vários estudos estão a ser feitos na tentativa de identi%car biomarcadores da
retinopatia diabética e edema macular, mas atualmente ainda não há dados con-
cretos.
Referências
1. Emanuele N, Moritz T, Klein R, et al. Ethnicity, race, and clinically signi%cant macu-
lar edema in the Veterans Affairs Diabetes Trial (VADT). Diabetes Res Clin Pract.
2009;86(2):104-110. doi:10.1016/j.diabres.2009.08.001.
2. Yin Wong T, Klein R, Amirul Islam F, et al. Diabetic Retinopathy in a Multi-ethnic
Cohort in the United States. Available at:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246042/pdf/nihms39850.pdf. Accessed July 16, 2017.
3. R. Varma, R. Klein, S.K. West, M. Torres, B. Klein, B. Munoz, S. Azen SM. Are Latinos at
Greater Risk for Diabetic Retinopathy Than Whites? Pooled Findings From 3 Population–
based Studies. Invest Ophthalmol Vis Sci. 2005;46(13):1164.
4. Nunes S, Ribeiro L, Lobo C, Cunha-Vaz J. Three Different Phenotypes of Mild Non-
proliferative Diabetic Retinopathy With Different Risks for Development of Clinically
Signi%cant Macular Edema. Invest Ophthalmol Vis Sci. 2013;54(7):4595. doi:10.1167/
iovs.13-11895.
5. Nunes S, Pires I, Rosa A, Duarte L, Bernardes R, Cunha-Vaz J. Microaneurysm turnover
is a biomarker for diabetic retinopathy progression to clinically signi%cant macular ede-
ma: Findings for type 2 diabetics with nonproliferative retinopathy. Ophthalmologica.
2009;223(5):292-297.
6. Simões MJ, Lobo C, Egas C, et al. Genetic Variants in ICAM1, PPARGC1A and MTHFR
Are Potentially Associated with Different Phenotypes of Diabetic Retinopathy. Ophthal-
mologica. 2014;232(3):156-162. doi:10.1159/000365229.
7. Cunha-Vaz J, Ribeiro L, Lobo C. Phenotypes and biomarkers of diabetic retinopathy. Prog
Retin Eye Res. 2014;41:90-111. doi:10.1016/j.preteyeres.2014.03.003.
8. Awata T, Kurihara S, Takata N, et al. Functional VEGF C-634G polymorphism is asso-
ciated with development of diabetic macular edema and correlated with macular reti-
nal thickness in type 2 diabetes. Biochem Biophys Res Commun. 2005;333(3):679-85.
doi:10.1016/j.bbrc.2005.05.167.
9. Nunes S, Ribeiro L, Lobo C, Cunha-Vaz J. Three different phenotypes of mild nonproli-
ferative diabetic retinopathy with different risks for development of clinically signi%cant
macular edema. Invest Ophthalmol Vis Sci. 2013;54(7):4595-604. doi:10.1167/iovs.13-
11895.
10. Morris AP, Voight BF, Teslovich TM, et al. Large-scale association analysis provides insi-
ghts into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet.
2012;44(9):981-90. doi:10.1038/ng.2383.
11. Visscher PM, Brown MA, McCarthy MI, Yang J. Five years of GWAS discovery. Am J Hum
Genet. 2012;90(1):7-24. doi:10.1016/j.ajhg.2011.11.029.
12. Kuo JZ, Wong TY, Rotter JI. Challenges in elucidating the genetics of diabetic retinopathy.
JAMA Ophthalmol. 2014;132(1):96-107. doi:10.1001/jamaophthalmol.2013.5024.
13. Hernández C, García-Ramírez M, Colomé N, et al. New pathogenic candidates for dia-
betic macular edema detected by proteomic analysis. Diabetes Care. 2010;33(7):e92.
doi:10.2337/dc10-0232.